The Clinical Value of D-D, AT-Ⅲ, NLR, PLT and ALB Measurement in Liver Diseases
Clinical Laboratory · 2026 · 72 (11/2026)
DOI: 10.7754/clin.lab.2025.251014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Laboratory, 2026. Verfasst von Chenhao Xia und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Liver Neoplasms, Fibrin Fibrinogen Degradation Products, Neutrophils, Lymphocytes.
Abstract (Originalsprache)
BACKGROUND: The aim is to investigate the clinical value of individual and combined assessment of plasma D-dimer (D-D), antithrombin III (AT-III), the neutrophil-to-lymphocyte ratio (NLR) and platelet count (PLT) in whole blood, as well as serum albumin (ALB) in the auxiliary diagnosis and clinical evaluation of liver diseases. METHODS: A total of 184 patients with hepatitis, cirrhosis, or hepatocellular carcinoma (HCC) admitted to our hospital between December 2024 and May 2025 were enrolled, together with 100 healthy individuals as controls. The levels of plasma D-D, AT-III, whole blood NLR, PLT, and serum ALB were measured. HCC patients were classified according to the China Liver Cancer (CNLC) staging system. Receiver operating characteristic (ROC) curves were used to evaluate the diagnostic performance of individual and combined markers. RESULTS: Compared with healthy controls, patients with liver diseases showed significant differences in D-D, AT-Ⅲ, PLT, NLR, and ALB levels. The benign liver disease group (hepatitis and cirrhosis) had lower AT-Ⅲ, PLT, and ALB levels than the HCC (malignant) group, while patients with stage II HCC exhibited lower AT-Ⅲ and NLR levels than those with stage III/IV HCC. ROC analysis revealed that D-D (AUC = 0.826) and reciprocal of ALB (1/ALB, AUC = 0.822) had diagnostic value in differentiating hepatitis from cirrhosis. The combined detection of these two markers exhibited superior diagnostic performance for differentiating patients with hepatitis and cirrhosis compared to either individual indicator, achieving a further increased AUC of 0.886. CONCLUSIONS: The levels of D-D, AT-Ⅲ, NLR, PLT, and ALB can serve as indicators reflecting the progression of various liver diseases. These parameters can provide valuable reference information for the auxiliary clinical diagnosis, monitoring of therapeutic efficacy, and prognosis assessment of liver diseases. Among these, AT-III and NLR are associated with the staging of HCC. Notably, the combined detection of D-D and ALB can enhance the predictive value for the diagnosis of hepatitis and liver cirrhosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Xia, C., Xing, Z., Li, J., Liu, C., Lv, K., & Li, X. (2026). The Clinical Value of D-D, AT-Ⅲ, NLR, PLT and ALB Measurement in Liver Diseases. Clinical Laboratory, 72(11/2026). https://doi.org/10.7754/clin.lab.2025.251014
Vancouver
Xia C, Xing Z, Li J, Liu C, Lv K, Li X. The Clinical Value of D-D, AT-Ⅲ, NLR, PLT and ALB Measurement in Liver Diseases. Clinical Laboratory. 2026;72(11/2026). doi:10.7754/clin.lab.2025.251014
BibTeX
@article{Xia2026,
author = {Xia, Chenhao and Xing, Zihe and Li, Jie and Liu, Caixin and Lv, Kun and Li, Xiaoning},
title = {The Clinical Value of D-D, AT-Ⅲ, NLR, PLT and ALB Measurement in Liver Diseases},
journal = {Clinical Laboratory},
year = {2026},
volume = {72},
number = {11/2026},
doi = {10.7754/clin.lab.2025.251014}
}
EUVIMED